Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 12/2021

01-12-2021 | Rectal Cancer | Review Article

The incidence and risk factors of low anterior resection syndrome (LARS) after sphincter-preserving surgery of rectal cancer: a systematic review and meta-analysis

Authors: Rui Sun, Ziyi Dai, Yin Zhang, Junyang Lu, Yuelun Zhang, Yi Xiao

Published in: Supportive Care in Cancer | Issue 12/2021

Login to get access

Abstract

Background

Many patients after sphincter-preserving surgery experienced anorectal functional disturbances which were known as low anterior resection syndrome (LARS). Although many studies investigated LARS, there was inconsistency of their assessment tools and results. The aim of this systematic review was to elucidate the incidence and risk factors of LARS by a validated tool—LARS score.

Methods

A systematic literature search in Pubmed, Embase, and Cochrane Library was conducted in April 2020. Studies investigating patients who were evaluated by LARS score 1 year after their sphincter-preserving surgery due to rectal cancer were included. Meta-analysis of incidence was conducted using the double arcsine method. Meta-analysis of each risk factor was conducted using a random effects model.

Results

A total of 50 studies were included. The pooled incidence of major LARS was 44% (95% CI 40–48%; I2 = 88%; 36 studies). Long course neoadjuvant radiotherapy (OR 2.89, 95% CI 2.06–4.05; I2 = 47%; P < 0.01; 10 studies), total mesorectal excision (TME) (OR 2.13, 95% CI 1.49–3.04; I2 = 53%; P < 0.01; 7 studies), anastomotic leak (OR 1.98, 95% CI 1.34–2.93; I2 = 39%; P < 0.01; 9 studies), and diverting stoma (OR 1.89, 95% CI 1.58–2.27; I2 = 0%; P < 0.01; 13 studies) were associated with increased risk of major LARS. No significant difference was found in major LARS incidence between transanal TME and laparoscopic TME (OR 1.36, 95% CI 0.78–2.40; I2 = 19%; P = 0.28; 4 studies). Pouch reconstruction failed to lower the risk of major LARS in long term (OR 1.43, 95% CI 0.88–2.33; I2 = 70%; P = 0.29; 9 studies).

Conclusion

The incidence of major LARS after sphincter-preserving surgery is relatively high. Neoadjuvant radiotherapy, TME, anastomostic leak, and diverting stoma are major risk factors. No significant differences in postoperative anorectal functions were observed between transanal and laparoscopic TME. Pouch reconstruction was not found to be significantly beneficial to anorectal functions in long term.
Appendix
Available only for authorised users
Literature
1.
Bregendahl S, Emmertsen KJ, Lous J et al (2013) Bowel dysfunction after low anterior resection with and without neoadjuvant therapy for rectal cancer: a population-based cross-sectional study[J]. Colorectal Dis 15(9):1130–1139PubMed
2.
Keane C, Fearnhead NS, Bordeianou LG et al (2020) International consensus definition of low anterior resection syndrome[J]. Dis Colon Rectum 63(3):274–284PubMedPubMedCentralCrossRef
3.
Jimenez-Gomez LM, Espin-Basany E, Marti-Gallostra M et al (2016) Low anterior resection syndrome: a survey of the members of the American Society of Colon and Rectal Surgeons (ASCRS), the Spanish Association of Surgeons (AEC), and the Spanish Society of Coloproctology (AECP)[J]. Int J Colorectal Dis 31(4):813–823PubMedCrossRef
4.
Emmertsen KJ, Laurberg S (2012) Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer[J]. Ann Surg 255(5):922–928PubMedCrossRef
5.
Emmertsen KJ, Laurberg S (2013) Impact of bowel dysfunction on quality of life after sphincter-preserving resection for rectal cancer[J]. Br J Surg 100(10):1377–1387PubMedCrossRef
6.
Bohlok A, Mercier C, Bouazza F et al (2020) The burden of low anterior resection syndrome on quality of life in patients with mid or low rectal cancer[J]. Support Care Cancer 28(3):1199–1206PubMedCrossRef
7.
Leão P, Santos C, Goulart A et al (2019) TaTME: analysis of the evacuatory outcomes and EUS anal sphincter[J]. Minim Invasive Ther Allied Technol 28(6):332–337PubMedCrossRef
8.
Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement[J]. J Clin Epidemiol 62(10):1006–1012PubMedCrossRef
9.
Higgins JPT G S. Cochrane handbook for systematic reviews of interventions.[M]. John Wiley & Sons: Chichester, 2011.
10.
Slim K, Nini E, Forestier D et al (2003) Methodological index for non-randomized studies (minors): development and validation of a new instrument[J]. ANZ J Surg 73(9):712–716PubMedCrossRef
11.
12.
Keane C, Park J, Öberg S et al (2019) Functional outcomes from a randomized trial of early closure of temporary ileostomy after rectal excision for cancer[J]. Br J Surg 106(5):645–652PubMedPubMedCentralCrossRef
13.
Sun W, Dou R, Chen J et al (2019) Impact of long-course neoadjuvant radiation on postoperative low anterior resection syndrome and quality of life in rectal cancer: post hoc analysis of a randomized controlled trial[J]. Ann Surg Oncol 26(3):746–755PubMedCrossRef
14.
Gadan S, Floodeen H, Lindgren R et al (2017) Does a defunctioning stoma impair anorectal function after low anterior resection of the rectum for cancer? A 12-Year follow-up of a randomized multicenter trial[J]. Dis Colon Rectum 60(8):800–806PubMedCrossRef
15.
Pontallier A, Denost Q, Van Geluwe B et al (2016) Potential sexual function improvement by using transanal mesorectal approach for laparoscopic low rectal cancer excision[J]. Surg Endosc 30(11):4924–4933PubMedCrossRef
16.
Chen TY, Wiltink LM, Nout RA et al (2015) Bowel function 14 years after preoperative short-course radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomized trial[J]. Clin Colorectal Cancer 14(2):106–114PubMedCrossRef
17.
Foo CC, Kin NK, Tsang JS et al (2020) Low anterior resection syndrome after transanal total mesorectal excision: a comparison with the conventional top-to-bottom approach[J]. Dis Colon Rectum 63(4):497–503PubMedCrossRef
18.
Keller DS, Reali C, Spinelli A et al (2019) Patient-reported functional and quality-of-life outcomes after transanal total mesorectal excision[J]. Br J Surg 106(4):364–366PubMedCrossRef
19.
Couwenberg AM, Burbach J, van Grevenstein W et al (2018) Effect of neoadjuvant therapy and rectal surgery on health-related quality of life in patients with rectal cancer during the first 2 years after diagnosis[J]. Clin Colorectal Cancer 17(3):e499–e512PubMedCrossRef
20.
Ihnát P, Slívová I, Tulinsky L et al (2018) Anorectal dysfunction after laparoscopic low anterior rectal resection for rectal cancer with and without radiotherapy (manometry study)[J]. J Surg Oncol 117(4):710–716PubMedCrossRef
21.
Luca F, Valvo M, Guerra-Cogorno M et al (2016) Functional results of robotic total intersphincteric resection with hand-sewn coloanal anastomosis[J]. Eur J Surg Oncol 42(6):841–847PubMedCrossRef
22.
Bondeven P, Emmertsen KJ, Laurberg S et al (2015) Neoadjuvant therapy abolishes the functional benefits of a larger rectal remnant, as measured by magnetic resonance imaging after restorative rectal cancer surgery[J]. Eur J Surg Oncol 41(11):1493–1499PubMedCrossRef
23.
Bolton W S, Chapman S J, Corrigan N, et al. The incidence of low anterior resection syndrome as assessed in an international randomized controlled trial (MRC/NIHR ROLARR)[J]. Ann Surg, 2020.
24.
Thyø A, Laurberg S, Emmertsen K J. Impact of bowel and stoma dysfunction on female sexuality after treatment for rectal cancer[J]. Colorectal Dis, 2020.
25.
Bjoern M X, Nielsen S, Perdawood S K. Quality of life after surgery for rectal cancer: a comparison of functional outcomes after transanal and laparoscopic approaches[M]. 2019.
26.
Eid Y, Bouvier V, Menahem B et al (2019) Digestive and genitourinary sequelae in rectal cancer survivors and their impact on health-related quality of life: Outcome of a high-resolution population-based study[J]. Surgery 166(3):327–335PubMedCrossRef
27.
Jimenez-Gomez L M, Espin-Basany E, Trenti L, et al. Factors associated with low anterior resection syndrome after surgical treatment of rectal cancer[J]. Colorectal Dis, 2017.
28.
Kupsch J, Jackisch T, Matzel KE et al (2018) Outcome of bowel function following anterior resection for rectal cancer-an analysis using the low anterior resection syndrome (LARS) score[J]. Int J Colorectal Dis 33(6):787–798PubMedCrossRef
29.
Nuytens F, Develtere D, Sergeant G et al (2018) Perioperative radiotherapy is an independent risk factor for major LARS: a cross-sectional observational study[J]. Int J Colorectal Dis 33(8):1063–1069PubMedCrossRef
30.
Ramage L, Mclean P, Simillis C et al (2018) Functional outcomes with handsewn versus stapled anastomoses in the treatment of ultralow rectal cancer[J]. Updates Surg 70(1):15–21PubMedPubMedCentralCrossRef
31.
Trenti L, Galvez A, Biondo S et al (2018) Quality of life and anterior resection syndrome after surgery for mid to low rectal cancer: a cross-sectional study[J]. Eur J Surg Oncol 44(7):1031–1039PubMedCrossRef
32.
Hain E, Manceau G, Maggiori L et al (2017) Bowel dysfunction after anastomotic leakage in laparoscopic sphincter-saving operative intervention for rectal cancer: a case-matched study in 46 patients using the Low Anterior Resection Score[J]. Surgery 161(4):1028–1039PubMedCrossRef
33.
Juul T, Battersby NJ, Christensen P et al (2015) Validation of the English translation of the low anterior resection syndrome score[J]. Colorectal Dis 17(10):908–916PubMedCrossRef
34.
Juul T, Ahlberg M, Biondo S et al (2014) Low anterior resection syndrome and quality of life: an international multicenter study[J]. Dis Colon Rectum 57(5):585–591PubMedCrossRef
35.
Kim CW, Jeong WK, Son GM et al (2020) Validation of Korean version of low anterior resection syndrome score questionnaire[J]. Ann Coloproctol 36(2):83–87PubMedPubMedCentralCrossRef
36.
van Heinsbergen M, den Haan N, Maaskant-Braat AJ et al (2020) Functional bowel complaints and quality of life after surgery for colon cancer: prevalence and predictive factors[J]. Colorectal Dis 22(2):136–145PubMedCrossRef
37.
Grosek J, Košir JA, Novak J et al (2019) Validation of the Slovenian version of the low anterior resection syndrome score for rectal cancer patients after surgery[J]. Zdr Varst 58(4):148–154PubMedPubMedCentral
38.
Pokharel N, Katwal G, Adhikari S K. Incidence of the bowel, bladder, and sexual dysfunction following surgery for colorectal malignancy[M]. 2019.
39.
van der Heijden J, van Heinsbergen M, Thomas G et al (2019) Implementation of a postoperative screening and treatment guidance for the low anterior resection syndrome: preliminary results[J]. Dis Colon Rectum 62(9):1033–1042PubMedCrossRef
40.
Veltcamp HM, Koedam T, Knol JJ et al (2019) Quality of life after rectal cancer surgery: differences between laparoscopic and transanal total mesorectal excision[J]. Surg Endosc 33(1):79–87CrossRef
41.
Yin Z, Zheng B, Wei M, et al. b-shaped laparoscopic dual anastomosis for mid-low rectal cancer: a safe and feasible technique[M]. 2019.
42.
Akizuki E, Matsuno H, Satoyoshi T et al (2018) Validation of the Japanese version of the low anterior resection syndrome score[J]. World J Surg 42(8):2660–2667PubMedPubMedCentralCrossRef
43.
Croese AD, Zubair ON, Lonie J et al (2018) Prevalence of low anterior resection syndrome at a regional Australian centre[J]. ANZ J Surg 88(12):E813–E817PubMedCrossRef
44.
Hupkens B, Breukink SO, Olde ROBC et al (2018) Dutch validation of the low anterior resection syndrome score[J]. Colorectal Dis 20(10):881–887PubMedCrossRef
45.
van Heinsbergen M, Janssen-Heijnen ML, Leijtens JW et al (2018) Bowel dysfunction after sigmoid resection underestimated: multicentre study on quality of life after surgery for carcinoma of the rectum and sigmoid[J]. Eur J Surg Oncol 44(8):1261–1267PubMedCrossRef
46.
Harsløf S, Stouge A, Thomassen N et al (2017) Outcome one year after robot-assisted rectal cancer surgery: a consecutive cohort study[J]. Int J Colorectal Dis 32(12):1749–1758PubMedCrossRef
47.
Jiménez-Rodríguez RM, Segura-Sampedro JJ, Rivero-Belenchón I et al (2017) Is the interval from surgery to ileostomy closure a risk factor for low anterior resection syndrome?[J]. Colorectal Dis 19(5):485–490PubMedCrossRef
48.
Qin Q, Huang B, Cao W et al (2017) Bowel Dysfunction after low anterior resection with neoadjuvant chemoradiotherapy or chemotherapy alone for rectal cancer: a cross-sectional study from China[J]. Dis Colon Rectum 60(7):697–705PubMedCrossRef
49.
Ribas Y, Aguilar F, Jovell-Fernández E et al (2017) Clinical application of the LARS score: results from a pilot study[J]. Int J Colorectal Dis 32(3):409–418PubMedCrossRef
50.
Sturiale A, Martellucci J, Zurli L et al (2017) Long-term functional follow-up after anterior rectal resection for cancer[J]. Int J Colorectal Dis 32(1):83–88PubMedCrossRef
51.
Beppu N, Kimura H, Matsubara N et al (2016) Long-Term functional outcomes of total mesorectal excision following chemoradiotherapy for lower rectal cancer: stapled anastomosis versus intersphincteric resection[J]. Dig Surg 33(1):33–42PubMedCrossRef
52.
Ekkarat P, Boonpipattanapong T, Tantiphlachiva K et al (2016) Factors determining low anterior resection syndrome after rectal cancer resection: a study in Thai patients[J]. Asian J Surg 39(4):225–231PubMedCrossRef
53.
Samalavicius NE, Dulskas A, Lasinskas M et al (2016) Validity and reliability of a Lithuanian version of low anterior resection syndrome score[J]. Tech Coloproctol 20(4):215–220PubMedCrossRef
54.
Beppu N, Matsubara N, Noda M et al (2015) Short-course radiotherapy with delayed surgery versus conventional chemoradiotherapy: a comparison of the short- and long-term outcomes in patients with T3 rectal cancer[J]. Surgery 158(1):225–235PubMedCrossRef
55.
Hou XT, Pang D, Lu Q et al (2015) Validation of the Chinese version of the low anterior resection syndrome score for measuring bowel dysfunction after sphincter-preserving surgery among rectal cancer patients[J]. Eur J Oncol Nurs 19(5):495–501PubMedCrossRef
56.
Ng KS, Russo R, Gladman MA (2020) Colonic transit in patients after anterior resection: prospective, comparative study using single-photon emission CT/CT scintigraphy[J]. Br J Surg 107(5):567–579PubMedCrossRef
57.
Temple LK, Bacik J, Savatta SG et al (2005) The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer[J]. Dis Colon Rectum 48(7):1353–1365PubMedCrossRef
58.
Croese AD, Lonie JM, Trollope AF et al (2018) A meta-analysis of the prevalence of low anterior resection syndrome and systematic review of risk factors[J]. Int J Surg 56:234–241PubMedCrossRef
59.
Buzatti K, Petroianu A (2017) Pathophysiological aspects of the low anterior resection syndrome for treatment of rectal cancer[J]. Rev Col Bras Cir 44(4):397–402PubMedCrossRef
60.
Benson AB, Venook AP, Al-Hawary MM et al (2018) Rectal cancer, Version 2 2018, NCCN Clinical Practice Guidelines in Oncology[J]. J Natl Compr Canc Netw 16(7):874–901PubMedCrossRef
61.
Brown G, Richards CJ, Bourne MW et al (2003) Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison[J]. Radiology 227(2):371–377PubMedCrossRef
62.
Quirke P, Steele R, Monson J et al (2009) Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial[J]. Lancet 373(9666):821–828PubMedPubMedCentralCrossRef
63.
Taylor FG, Quirke P, Heald RJ et al (2011) Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study[J]. Ann Surg 253(4):711–719PubMedCrossRef
64.
Marti WR, Curti G, Wehrli H et al (2019) Clinical outcome after rectal replacement with side-to-end, colon-j-pouch, or straight colorectal anastomosis following total mesorectal excision: a Swiss prospective, randomized, multicenter trial (SAKK 40/04)[J]. Ann Surg 269(5):827–835PubMedCrossRef
65.
Brown C J, Fenech D, McLeod R S. Reconstructive techniques after rectal resection for rectal cancer[J]. Cochrane Database of Systematic Reviews, 2008(2).
Metadata
Title
The incidence and risk factors of low anterior resection syndrome (LARS) after sphincter-preserving surgery of rectal cancer: a systematic review and meta-analysis
Authors
Rui Sun
Ziyi Dai
Yin Zhang
Junyang Lu
Yuelun Zhang
Yi Xiao
Publication date
01-12-2021
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 12/2021
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-021-06326-2

Other articles of this Issue 12/2021

Supportive Care in Cancer 12/2021 Go to the issue

Original Article

Personality matters: relationship between personality characteristics, spirituality, demoralization, and perceived quality of life in a sample of end-of-life cancer patients

Original Article

Moderators of intervention efficacy for Finding My Way: A web-based psychosocial intervention for cancer-related distress

Original Article

Subgroups of patients undergoing chemotherapy with distinct cognitive fatigue and evening physical fatigue profiles

Original Article

A hybrid model of acute unscheduled cancer care provided by a hospital-based acute care clinic and the emergency department: a descriptive study

Original Article

The efficacy of music therapy to relieve pain, anxiety, and promote sleep quality, in patients with small cell lung cancer receiving platinum-based chemotherapy

Original Article

Factors related to specialized palliative care use and aggressive care at end of life in Japanese patients with advanced solid cancers: a cohort study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits